PubMed Journals Articles About "Indiana Blood And Marrow Transplantation" RSS

13:44 EDT 23rd July 2018 | BioPortfolio

Indiana Blood And Marrow Transplantation PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Indiana Blood And Marrow Transplantation articles that have been published worldwide.

More Information about "Indiana Blood And Marrow Transplantation" on BioPortfolio

We have published hundreds of Indiana Blood And Marrow Transplantation news stories on BioPortfolio along with dozens of Indiana Blood And Marrow Transplantation Clinical Trials and PubMed Articles about Indiana Blood And Marrow Transplantation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Indiana Blood And Marrow Transplantation Companies in our database. You can also find out about relevant Indiana Blood And Marrow Transplantation Drugs and Medications on this site too.

Showing "Indiana Blood Marrow Transplantation" PubMed Articles 1–25 of 11,000+

Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.

Cytomegalovirus infection among cord-blood allogeneic transplantation recipients: low incidence of cytomegalovirus events without high-dose valacyclovir prophylaxis.

Perceived Workforce Challenges among Clinical Social Workers in Hematopoietic Cell Transplantation Programs.

In the Era of BCR-ABL1 Inhibitors, are We Closing the Survival Gap between Allogeneic Hematopoietic Cell Transplantation and Chemotherapy for Ph+ ALL in First Complete Remission?

Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study.

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality.

Biomarkers measured in blood chemistry before allogeneic hematopoietic stem cell transplantation (HSCT) may reflect patients' physiological status. We hypothesized that selected markers are predictive for non-relapse mortality (NRM) following transplantation and could contribute to risk assessment.

Get Outta' Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome.

Umbilical Cord Blood Expansion: are We There Yet?

Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.

Chemo-Mobilization in Myeloma-Diminishing Returns in the Era of Novel Agent Induction?

Chronic Graft Versus Host Disease - a Long Road Ahead.

Microbiome-Host Interactions in Hematopoietic Stem-Cell Transplant Recipients.

Allogeneic HSCT to Cure Transfusion Dependent Thalassemia: Timing Matters!

Primed to Kill: CTV-1 Stimulated Haploidentical Natural Killer Cells for Consolidation of AML.

Response to letter to editor for YBBMT-D-18-00212.

Hemorrhagic Cystitis: Brighter Days Ahead.

Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.

TBI: To Be (Irradiated) or not to be? That remains the question.

ASBMT Practice Guidelines Committee Survey on Long Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.

Reply to author.

Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.

Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes.

Platelet transfusion refractoriness (PTR) is frequently observed after allogeneic hematopoietic cell transplantation (HCT). However, the incidence of and risk factors for PTR, and impact of PTR on transplant outcomes after cord blood transplantation (CBT) have not been fully investigated. We retrospectively analyzed 185 adult patients who received single-unit CBT in our institute. The mean 16-hour corrected count increment (CCI) for the 5,840 platelet transfusions was 3.68×10/l. Among them, 3,196 transfusi...

Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.

In a secondary analysis of a randomized controlled trial (RCT), we examined engagement with INSPIRE, a personalized online program for hematopoietic cell transplantation (HCT) survivors that focused on cancer-related distress, depression, fatigue, and health care needs.

Risk of Exposure to Zika Virus and Impact on Cord Blood Banking and Adult Unrelated Donors in Hematopoietic Cell Transplantation: the Canadian Blood Services Experience.

Zika virus has emerged as a potential threat to the Canadian blood supply system. Stem cell donors within Canadian Blood Services' Cord Blood Bank (CBB) and OneMatch Stem Cell and Marrow Network (OM) now undergo screening measures designed to reduce the risk of Zika virus transmission. The impact these screening measures have on cord blood and unrelated adult stem cell donations is currently unknown.

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.

To evaluate the outcome of a salvage third autologous stem cell transplantation (ASCT) in relapsed multiple myeloma.

Quick Search